Dr. Wang’s research focuses on the epidemiology of cardiovascular disease. Areas of recent interest include:
1. left bundle branch block-associated idiopathic nonischemic cardiomyopathy
2. oral anticoagulation for left atrial thrombi resolution in nonvalvular atrial fibrillation or flutter
3. heart rhythm disorders and pregnancy
4. dual atrioventricular nodal nonreentrant tachycardia
Dr. Wang is board-certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease, and clinical cardiac electrophysiology. His clinical duties are primarily at UPMC Presbyterian Hospital and UPMC Passavant Hospital. As a cardiac electrophysiologist, he is trained in the diagnosis and treatment of a wide array of heart rhythm disorders. His procedural expertise includes cardiovascular implantable electronic devices (i.e. pacemakers, left bundle branch area pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization therapy) and catheter ablation of arrhythmias, including complex catheter ablation for atrial fibrillation and ventricular tachycardia.
Dr. Wang has an interest in global health care. He has on-going participation in medical missions in Cambodia with Jeremiah’s Hope since 2019. In addition, he was a member of a medical mission to Bolivia with Project Pacer International in 2016.
- BS, Northwestern University
- MD, Northwestern University
- MS, University of Pittsburgh
- Residency, Internal Medicine, Northwestern University
- Fellowship, Cardiovascular Diseases, Northwestern University
- Fellowship, Clinical Cardiac Electrophysiology, Northwestern University
Education & Training
Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett Jr JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M, for the EVEREST Investigators. Clinical Implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008; 29(22): 2656-2666.
Wang NC. Dual atrioventricular nodal nonreentrant tachycardia: a systematic review. Pacing and Clinical Electrophysiology. 2011; 34: 1671-1681.
Wang NC, Singh M, Adelstein EC, Jain SK, Mendenhall GS, Shalaby AA, Voigt AH, Saba S. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies. The NEOLITH study. Heart Rhythm. 2016; 13(4): 933-942.
Wang NC, Li JZ, Adelstein EC, Althouse AD, Sharbaugh MS, Jain SK, Mendenhall GS, Shalaby AA, Voigt AH, Saba S. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study. Pacing and Clinical Electrophysiology. 2018; 41(2): 143-154.
Wang NC, Sather MD, Hussain A, Althouse AD, Adelstein EC, Jain SK, Katz WE, Shalaby AA, Voigt AH, Saba S. Oral anticoagulation and left atrial thrombi resolution in non-rheumatic atrial fibrillation or flutter: A systematic review and meta-analysis. Pacing and Clinical Electrophysiology. 2018; 41(7): 767-774.
Hussain A, Katz WE, Genuardi MV, Bhonsale A, Jain SK, Kancharla K, Saba S, Shalaby AA, Voigt AH, Wang NC. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter. Pacing and Clinical Electrophysiology. 2019; 42(9): 1183-1190.
Wang NC, Lahiri MK, Thosani AJ, Shen S, Goldberger JJ. Reflections on the early invasive clinical cardiac electrophysiology era through fifty manuscripts: 1967-1992. Journal of Arrhythmia. 2019; 35(1): 7-17.
